ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,187.67
0.00%
Dow Jones
39,056.39
0.44%
US Dollar vs MXN
16.9482
0.17%
Brent Oil
83.79
0.28%
Bitcoin
61,051.44
-0.22%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Alaunos Therapeutics Inc (TCRT)

  7. Alaunos Therapeutics Inc (TCRT) Noticias

TCRT

Alaunos Therapeutics (TCRT)

Alaunos Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:TCRT
FechaHoraFuenteTítuloSímboloCompañía
28/02/202420:46Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TCRTAlaunos Therapeutics Inc
22/02/202415:44Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
14/02/202411:43Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TCRTAlaunos Therapeutics Inc
23/01/202416:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TCRTAlaunos Therapeutics Inc
14/11/202306:30GlobeNewswire Inc.Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic AlternativesNASDAQ:TCRTAlaunos Therapeutics Inc
01/09/202311:20Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TCRTAlaunos Therapeutics Inc
14/08/202315:37Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TCRTAlaunos Therapeutics Inc
14/08/202315:05GlobeNewswire Inc.Alaunos Therapeutics Announces Second Quarter 2023 Financial Results, Interim Clinical Data and Exploration of Strategic AlternativesNASDAQ:TCRTAlaunos Therapeutics Inc
29/06/202306:00GlobeNewswire Inc.Alaunos Therapeutics Announces Presentation at the 2nd Hawaii Global Summit on Thoracic MalignanciesNASDAQ:TCRTAlaunos Therapeutics Inc
12/06/202315:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCRTAlaunos Therapeutics Inc
08/06/202316:25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRTAlaunos Therapeutics Inc
25/05/202316:00GlobeNewswire Inc.Alaunos Therapeutics to Present Early Data from TCR-T Library Phase 1/2 Trial at 2023 American Society of Clinical Oncology Annual MeetingNASDAQ:TCRTAlaunos Therapeutics Inc
10/05/202306:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TCRTAlaunos Therapeutics Inc
10/05/202306:00GlobeNewswire Inc.Alaunos Therapeutics Reports First Quarter 2023 Financial ResultsNASDAQ:TCRTAlaunos Therapeutics Inc
03/05/202307:30GlobeNewswire Inc.Alaunos Therapeutics to Report First Quarter 2023 Financial Results on May 10, 2023NASDAQ:TCRTAlaunos Therapeutics Inc
26/04/202311:30GlobeNewswire Inc.Alaunos Therapeutics Announces Poster Presentation at the American Society of Clinical Oncology (ASCO) 2023 Annual MeetingNASDAQ:TCRTAlaunos Therapeutics Inc
25/04/202316:07Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:TCRTAlaunos Therapeutics Inc
19/04/202315:31Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TCRTAlaunos Therapeutics Inc
14/04/202316:06Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:TCRTAlaunos Therapeutics Inc
30/03/202306:00GlobeNewswire Inc.Alaunos Therapeutics Appoints Dr. Robert J. Hofmeister to Board of DirectorsNASDAQ:TCRTAlaunos Therapeutics Inc
29/03/202316:30GlobeNewswire Inc.Alaunos Therapeutics to Participate in Upcoming Investor Conferences in AprilNASDAQ:TCRTAlaunos Therapeutics Inc
07/03/202306:32Edgar (US Regulatory)Annual Report (10-k)NASDAQ:TCRTAlaunos Therapeutics Inc
07/03/202306:00GlobeNewswire Inc.Alaunos Therapeutics Reports Fourth Quarter and Full Year 2022 Financial ResultsNASDAQ:TCRTAlaunos Therapeutics Inc
28/02/202315:01GlobeNewswire Inc.Alaunos Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023NASDAQ:TCRTAlaunos Therapeutics Inc
14/02/202312:31Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TCRTAlaunos Therapeutics Inc
09/01/202307:30GlobeNewswire Inc.Alaunos Therapeutics Highlights Strategic Priorities and Anticipated Portfolio Milestones for 2023NASDAQ:TCRTAlaunos Therapeutics Inc
29/11/202208:01GlobeNewswire Inc.Alaunos Therapeutics Announces Pricing of Public Offering of Common StockNASDAQ:TCRTAlaunos Therapeutics Inc
28/11/202215:01GlobeNewswire Inc.Alaunos Therapeutics Announces Proposed Public Offering of Common StockNASDAQ:TCRTAlaunos Therapeutics Inc
15/11/202205:25TipRanksH.C. Wainwright Sticks to Their Hold Rating for Alaunos Therapeutics (TCRT)NASDAQ:TCRTAlaunos Therapeutics Inc
14/11/202206:00GlobeNewswire Inc.Alaunos Therapeutics Reports Third Quarter 2022 Financial ResultsNASDAQ:TCRTAlaunos Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:TCRT

Su Consulta Reciente

NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
ADDYY
Adidas (QX)
FX
EURMXN
Euro vs MXN
USOTC
RHHBY
Roche (QX)
NYSE
MCD
McDonalds
CCOM
US500
US 500
USI
USTECH100
US Tech 100
NYSE
BAC
Bank of America
AMEX
SPY
SPDR S&P 500
COIN
SOLUSD
Solana
NYSE
CVX
Chevron
USOTC
BNPQY
BNP Paribas (QX)
USOTC
DTEGY
Deutsche Telekom (QX)
PM
XAUUSD
Gold vs US Dollar
NYSE
VZ
Verizon Communications
NYSE
AXP
American Express
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados